Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autologous, Bone Marrow-Derived Mesenchymal Stem Cell-Derived Neural Progenitor Cells (MSC-NP), Expanded Ex Vivo; Administered Intrathecally

NCT03355365 is registered in ClinicalTrials.gov with Tisch Multiple Sclerosis Research Center of New York as lead sponsor.

NCT NCT03355365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03355365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autologous, Bone Marrow-Derived Mesenchymal Stem Cell-Derived Neural Progenitor Cells (MSC-NP), Expanded Ex Vivo; Administered Intrathecally
Lead sponsor
Tisch Multiple Sclerosis Research Center of New York
Phase
Phase 2
Overall status
Completed
Start date
September 21, 2018
Completion date
April 17, 2023
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis